Jun 28 |
Eliem Therapeutics: Year End 2024 MN Data With Further Potential To Unlock Value
|
Jun 28 |
Eliem Therapeutics to join the Russell 2000 and Russell 3000 indexes
|
Jun 28 |
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
|
Jun 27 |
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
|
Apr 11 |
Nasdaq Jumps 250 Points; Crude Oil Down 1%
|
Apr 11 |
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal
|
Apr 11 |
Eliem Therapeutics to buy Tenet, announces $120 million private placement
|
Apr 11 |
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
|
Mar 6 |
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
|